Weiss Multi-Strategy Advisers’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-10,353
Closed -$496K 709
2020
Q2
$496K Buy
10,353
+353
+4% +$27.3K 0.01% 468
2020
Q1
$630K Hold
10,000
0.02% 331
2019
Q4
$1.24M Sell
10,000
-4,000
-29% -$358K 0.02% 468
2019
Q3
$929K Buy
14,000
+1,000
+8% +$67.2K 0.02% 453
2019
Q2
$1.03M Buy
13,000
+5,000
+63% +$448K 0.03% 375
2019
Q1
$895K Buy
+8,000
New +$874K 0.02% 407
2017
Q1
Sell
-2,000
Closed -$217K 652
2016
Q4
$217K Hold
2,000
0.01% 381
2016
Q3
$329K Buy
2,000
+177
+10% +$27.9K 0.02% 372
2016
Q2
$260K Sell
1,823
-6,177
-77% -$901K 0.02% 363
2016
Q1
$1.03M Sell
8,000
-1,000
-11% -$118K 0.04% 333
2015
Q4
$1.34M Sell
9,000
-4,000
-31% -$677K 0.09% 213
2015
Q3
$2.16M Sell
13,000
-7,000
-35% -$1.54M 0.1% 179
2015
Q2
$4.83M Sell
20,000
-5,000
-20% -$1.33M 0.19% 140
2015
Q1
$7.05M Sell
25,000
-2,100
-8% -$455K 0.31% 87
2014
Q4
$4.23M Sell
27,100
-200
-0.7% -$36.9K 0.15% 138
2014
Q3
$6.46M Buy
27,300
+1,300
+5% +$331K 0.16% 156
2014
Q2
$6.15M Sell
26,000
-3,200
-11% -$843K 0.13% 178
2014
Q1
$9.63M Sell
29,200
-33,300
-53% -$11.2M 0.19% 137
2013
Q4
$4.27M Buy
62,500
+22,500
+56% +$1.3M 0.09% 258
2013
Q3
$2.76M Hold
40,000
0.06% 301
2013
Q2
$1.79M Buy
+40,000
New +$1.37M 0.05% 332

Other funds holding ICPT

Weiss Multi-Strategy Advisers's ICPT Position: Q3 2020 in Review

Weiss Multi-Strategy Advisers sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2020, closing a stake of 10,353 shares — an estimated $496K sold.

Weiss Multi-Strategy Advisers first reported a position in ICPT in Q2 2013 and held it in 21 quarters. The position peaked at $9.63M in Q1 2014. 177 funds tracked by Wall St. Rank hold ICPT as of Q3 2020.

  • Weiss Multi-Strategy Advisers reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 10,353 Intercept Pharmaceuticals, Inc. shares in Q3 2020, an estimated $496K.
  • Weiss Multi-Strategy Advisers first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 21 quarters.
  • Weiss Multi-Strategy Advisers's Intercept Pharmaceuticals, Inc. position peaked at $9.63M in Q1 2014.
  • 177 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2020, filed 16 Nov 2020.